The effect of a lutein based nutritional supplement on non-exudative age-related macular degeneration (AMD): a double-masked randomised controlled trial
ISRCTN | ISRCTN78467674 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN78467674 |
Secondary identifying numbers | N/A |
- Submission date
- 20/06/2003
- Registration date
- 11/09/2003
- Last edited
- 11/01/2018
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English Summary
Not provided at time of registration
Contact information
Miss Hannah Bartlett
Scientific
Scientific
Neuroscience Research Institute
School of Life and Health Sciences
Aston University
Aston Triangle
Birmingham
B4 7ET
United Kingdom
bartlehe@aston.ac.uk |
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Not specified |
Study type | Treatment |
Scientific title | The effect of a lutein based nutritional supplement on non-exudative age-related macular degeneration (AMD): a double-masked randomised controlled trial |
Study hypothesis | Age-related macular degeneration is the leading cause of blind registration in the developed world. One aetiological hypothesis involves oxidation and the intrinsic vulnerability of the retina to damage via this process. This has prompted interest in the role of antioxidants in the prevention and treatment of this eye disease. |
Ethics approval(s) | Approved by the Aston University Human Sciences Ethical Committee. |
Condition | Age-related macular degeneration |
Intervention | The study formulation contains: Lutein 10 mg Vitamin C 250 mg Vitamin E 34 mg Vitamin A 750 µg Zinc 10 mg Copper 0.5 mg |
Intervention type | Supplement |
Primary outcome measure | 1. Distance and near Visual Acuity (VA) measured using Bailey-Lovie logMAR charts 2. Contrast sensitivity (CS) measured using a Pelli-Robson chart 3. Colour vision measured using the PV-16 quantitative colour vision test 4. Macular Mapping (MM) test 5. Eger Macular Stressometer (EMS) used to assess glare recovery 6. Fundus photographs of the macular will be assessed using colour and edge analysis software Data collection will take place at baseline, nine, and 18 months. |
Secondary outcome measures | Not provided at time of registration |
Overall study start date | 01/07/2003 |
Overall study end date | 01/01/2005 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Not Specified |
Sex | Not Specified |
Target number of participants | 159 |
Participant inclusion criteria | 1. Have to provide written informed consent 2. Have to be available for three visits to Aston University 3. Have to present with no ocular pathology in one eye, or no ocular pathology other than dry AMD in one eye. A cataract grading system consisting of grades one, two and three for each of cortical, nuclear, and posterior subcapsular cataracts has been developed. Participants presenting with lens opacities precluding fundus photography are excluded. Throughout the trial period, progression of any type of cataract to the successive grade will require the participant to withdraw. |
Participant exclusion criteria | Exclusion criteria include type I and II diabetes because vitamin E has been shown to affect glucose tolerance and diabetic retinopathy may confound the results. Those taking Warfarin medication are excluded as zinc may decrease its absorption and activity, as are those who use nutritional supplements that potentially raise vitamin and mineral intake above safe limits. The most recent guidelines for upper limits of nutritional supplementation are set out in the UK Food Standards Agency report. Neovascular AMD and other ocular disease that could potentially interfere with the results are excluded. |
Recruitment start date | 01/07/2003 |
Recruitment end date | 01/01/2005 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Neuroscience Research Institute
Birmingham
B4 7ET
United Kingdom
B4 7ET
United Kingdom
Sponsor information
Aston University (UK)
University/education
University/education
Neurosciences Research Institute
School of Life and Health Sciences
Aston Triangle
Birmingham
B4 7ET
England
United Kingdom
Website | http://www.aston.ac.uk/ |
---|---|
https://ror.org/05j0ve876 |
Funders
Funder type
University/education
College of Optometrists (UK)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Protocol article | protocol | 10/10/2003 | Yes | No | |
Results article | results | 01/04/2008 | Yes | No |
Editorial Notes
11/01/2018: publication reference added.